Dr. Ann Simon has successful track record in the life sciences and technology sectors and has worked with numerous companies providing support and advice in the areas of finance, strategic planning and funding to development-stage life sciences companies. At Immune Regulation, Ann has responsibility for legal, corporate governance and financial planning.
She spent more than a decade in corporate finance advisory at Cazenove & Co. in City of London advising clients ranging from start-ups to FTSE100 companies. She has managed IPOs (London full list and AIM), corporate acquisitions and trade sales and fund raisings in the public and private markets.
Over the past 15 years she has held numerous executive and non-executive roles including Chairman of OBS Medical and CFO of Pyreos, mLED, Sphere Medical Holding, Genosis, Mirada Solutions, NextGen Sciences, e-San and Bioglan Pharma. She is currently a Non-Executive Director of Scientific Digital Imaging (where she chairs the audit committee), Spectrum General in connection with the Rainbow Seed Fund and Lumacron.